基本資料
種類: ETF
費用比率%: 0.36
資產淨值: 106.52
成立日期: 20/12/2011
 
分析
市值分佈:
99.74%
大市值
0.26%
中市值
--
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 25  
0%
 
100%
     10大 (73.10%)
代號 名稱 佔比% 持有日期
LLYEli Lilly & Co18.8528/02/2026
NVSNovartis AG11.3828/02/2026
MRKMerck & Co9.7028/02/2026
GSKGSK plc4.8928/02/2026
BMYBristol-Myers Squibb Co4.8828/02/2026
MCKMcKesson Corp4.8728/02/2026
JNJJohnson & Johnson4.8228/02/2026
PFEPfizer4.7728/02/2026
AZNAstraZeneca PLC4.5528/02/2026
NVONovo-Nordisk A/S4.4028/02/2026
ABBVABBVIE4.1328/02/2026
CORCencora4.0528/02/2026
SNYSanofi ADS4.0428/02/2026
ZTSZOETIS3.3628/02/2026
HLNHaleon plc3.0428/02/2026
TAKTakeda Pharmaceutical Company Limited2.8828/02/2026
TEVATeva Pharmaceutical Industries Limited2.6228/02/2026
VTRSViatris0.8328/02/2026
JAZZJazz Pharmaceuticals plc0.6628/02/2026
ELANElanco Animal Health0.4728/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.